SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-006402
Filing Date
2022-03-09
Accepted
2022-03-09 16:16:34
Documents
16
Period of Report
2022-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47858
2 ex99-1.htm EX-99.1 5240
3 ex99-1_001.jpg GRAPHIC 266286
4 ex99-1_002.jpg GRAPHIC 222934
5 ex99-1_003.jpg GRAPHIC 132749
  Complete submission text file 0001493152-22-006402.txt   1083391

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sigy-20220309.xsd EX-101.SCH 3060
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sigy-20220309_lab.xml EX-101.LAB 34476
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sigy-20220309_pre.xml EX-101.PRE 22613
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3411
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55575 | Film No.: 22725558
SIC: 3841 Surgical & Medical Instruments & Apparatus